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Abstract: 17 
We report our recent efforts directed at improving high-field DNP experiments. We 18 
investigated a series of thiourea nitroxide radicals and the associated DNP enhancements ranging 19 
from ε = 25 to 82 that demonstrate the impact of molecular structure on performance. We directly 20 
polarized low-gamma nuclei including 13C, 2H, and 17O using trityl via the cross effect. We 21 
discuss a variety of sample preparation techniques for DNP with emphasis on the benefit of 22 
methods that do not use a glass-forming cryoprotecting matrix. Lastly, we describe a corrugated 23 
waveguide for use in a 700 MHz / 460 GHz DNP system that improves microwave delivery and 24 
increases enhancement up to 50%. 25 
Introduction 26 
During the past two decades, magic-angle spinning (MAS) NMR spectroscopy has 27 
emerged as an excellent analytical method to determine atomic-resolution structures in various 28 
chemical systems including pharmaceuticals,1-3 membrane proteins,4-8 and amyloid fibrils.9-13 29 
Unfortunately, NMR sensitivity is inherently low and consequently many experiments require 30 
long acquisition times to achieve adequate signal-to-noise. A promising route to increase NMR 31 
sensitivity is via dynamic nuclear polarization (DNP), which seeks to polarize nuclear spins using 32 
electron polarization transferred via microwave irradiation of electron-nuclear transitions.  In 33 
particular, the method has been shown to provide increases in polarization upwards of 2 to 3 34 
orders of magnitude.14-20 35 
 36 
V15_131025 
3 
Dynamic nuclear polarization was initially demonstrated in the 1950s at low magnetic 37 
fields. Following the groundbreaking work of Overhauser,21 Carver, and Slichter,22 various 38 
polarization-transfer mechanisms were studied in the 1960s and 1970s including the solid effect 39 
(SE),23-25 the cross effect (CE),26-30 and thermal mixing (TM).18,31-33 However, the theoretical 40 
understanding of the DNP mechanisms suggested limited applicability at magnetic fields beyond 41 
1 T. This was followed by a brief exploration of applications of DNP to polymers at low fields 42 
(1.4 T) by Wind et al.18, Schaefer and co-workers.34,35 Moreover, DNP experiments at higher 43 
fields (≥ 5T) was hindered by the lack of stable, high-power microwave devices operating at the 44 
necessary high frequencies (e.g., 100 to 600 GHz) and also by the absence of low-temperature, 45 
high-resolution MAS NMR probes that offer both effective microwave coupling as well as the 46 
required sample cooling. Together these barriers prevented DNP from being widely applicable in 47 
the decades following its discovery. In the early 1990’s, our laboratory introduced high frequency 48 
gyrotron (a.k.a. cyclotron resonance maser) sources to magnetic resonance and DNP in particular 49 
since they can reliably provide high-frequency microwaves.36 They have now made high-field 50 
DNP viable for many applications. Combined with the improved resolution offered with higher-51 
field MAS experiments, DNP can now be used to investigate many chemically challenging 52 
systems and areas of NMR spectroscopy including biological solids37-41, surface chemistry42, and 53 
systems involving difficult NMR-active nuclei (e.g., low natural abundance, low gamma and / or 54 
quadrupolar).43-49  55 
The DNP mechanism involves microwave irradiation of the EPR transitions of a 56 
paramagnetic polarizing agent that transfers the large spin polarization of electrons to nearby 57 
nuclei. In order to accomplish this at contemporary NMR fields (i.e., 200 to 1000 MHz), three 58 
criteria must be met: i.) a stable high-frequency microwave source (≥ 102 GHz), ii.) a reliable 59 
cryogenic MAS probe with adequate microwave waveguide delivery, and iii.) a suitable 60 
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polarizing agent for the sample under study. The first criterion was met by the aforementioned 61 
gyrotrons, which are fast wave devices that can deliver the appropriate frequency range for 62 
stimulation of the EPR transitions at high fields, and they can be operated stably and 63 
continuously over an extended period of time (i.e., weeks to months).50 Second, to date DNP is 64 
optimally performed at cryogenic temperatures to decrease electron and nuclear relaxation rates 65 
in order to increase the obtainable non-Boltzmann polarization. To achieve the desired 66 
temperature (80-100 K) typically requires a specially designed heat exchanger / dewar system,51 67 
vacuum-jacketed gas-transfer lines, and optional pre-chillers.52,53 The complexity of this 68 
instrumentation is further compounded by the need for MAS in order to obtain high resolution 69 
spectra, meaning that carefully designed and constructed multichannel (e.g., 1H/13C/15N/e-) low-70 
temperature MAS NMR probes are essential.54 The third requirement is the availability of 71 
paramagnetic species (polarization agents) that is the polarization source for various chemical 72 
systems. The polarizing agent can be exogenous or endogenous and most often comes in the form 73 
of a free radical. It should be compatible with the chemical system (e.g., non-reactive), able to 74 
yield large DNP enhancements, and chemically robust. Depending on the application, the radicals 75 
and experimental conditions can be developed to optimize a specific DNP mechanism55,56 such as 76 
SE or CE. 77 
Over the past two decades, development of high-field DNP has focused primarily on 78 
using the CE mechanism, since the typical SE enhancements had been considerably lower.57 79 
Below we make mention of both the SE and CE mechanism as recent results have shown that the 80 
SE may be useful for polarization using transition-metal based polarizing agents58 and recently 81 
been observed to provide significant enhancements ~100.59,60 Furthermore, with the continued 82 
development of equipment producing increased microwave field strengths, the enhancements and 83 
sensitivity may match those of CE.61 The dominant polarization transfer process (SE or CE) 84 
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depends on the NMR-active nuclei being polarized and also the EPR characteristics of the 85 
specific polarizing agent. Particularly, the relative magnitudes of the electron homogeneous (δ) 86 
and inhomogeneous (Δ) linewidths, and the nuclear Larmor frequency (ω0I) are the most 87 
important factors to determine the dominant polarization mechanism.  88 
The SE mechanism, shown in Scheme 1, is a two-spin process which is dominant when 89 
ω0I > δ, Δ and microwave irradiation is applied at the electron-nuclear zero- or double-quantum 90 
transition.24,25,59,60  This matching condition is given by: 91 
 ωmw =ω 0S ±ω 0 I  (1) 
where ω0S is the electron Larmor frequency and ωmw is the microwave frequency. For SE, since 92 
the microwave frequency required must match the condition given in Eq. (1), a polarizing agent 93 
with a narrow EPR spectrum is typically used, with an electron T1S that is optimized to allow 94 
efficient polarization of nearby nuclei without introducing large signal quenching.  95 
 96 
Scheme 1: Spin population distribution for a two-spin (1 electron and 1 nucleus) system at thermal 97 
equilibrium (A). SE conditions for the positive, ω0S – ω0I (B) and negative enhancement, ω0S + ω0I (C).  98 
The CE mechanism may be described as a three-spin flip-flop-flip process between two 99 
electrons and a nucleus, which is dominant when Δ > ω0I > δ. In order to achieve maximum 100 
efficiency, the difference between the two electron Larmor frequencies must be near the nuclear 101 
Larmor frequency.26,28,62,63 102 
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ω 0 I =ω 0S2 −ω 0S1
 
(2) 
For CE64, a radical with a broad EPR linewidth, particularly a nitroxide based radical, is often 103 
used to satisfy the condition provided in Eq. (2). CE is often the choice for high-field DNP 104 
experiments due to this mechanism being based on allowable transitions unlike the SE. Scheme 2 105 
shows the energy level diagram for the CE mechanism.  106 
 107 
Scheme 2: Spin population distribution for a three-spin (2 electrons and 1 nucleus) system at thermal 108 
equilibrium with the NMR transitions marked (A). The CE condition for the negative (B) and positive (C) 109 
enhancement. Microwave saturation of the electron transition (ω0S1 or ω0S2)  leads to a three-spin flip-flop-110 
flip process that distributes the population (ωCE), thus increasing the net nuclear polarization.   111 
The descriptions for the CE and the SE DNP mechanism, vide supra, do not incorporate 112 
sample rotation. That is, the effects of MAS on modulating energy levels that create level 113 
crossings and impact polarization transfer. Recently, Thurber and Tycko65 and Mentink-Vigier et 114 
al.66 discussed the CE mechanism in MAS, while showed experimental MAS DNP NMR data on 115 
the SH3 protein and described theoretical models of the effect MAS has on both the CE and the 116 
SE mechanism.  117 
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In this paper, we provide a brief overview of recent developments in high-field DNP at 118 
the Francis Bitter Magnet Lab at MIT, including polarizing agents, sample preparation methods, 119 
and improvements to the 700 MHz / 460 GHz DNP spectrometer.  120 
 121 
i. Development of CE Biradicals 122 
Nitroxide monoradicals (e.g., TEMPOL) were popular in early high-field DNP 123 
experiments. They are suited for CE DNP of 1H because the breadth of the EPR spectrum is of 124 
the order of ~600 MHz.67 They are also low-cost, commercially available, highly water-soluble, 125 
and offer reasonable DNP enhancements between ε =20 to 50.36,68 For these monoradicals, a 126 
concentration of up to 40 mM usually provides the best signal enhancements. However, at these 127 
elevated electron concentrations, paramagnetic relaxation strongly competes with DNP 128 
enhancement and only provides moderate electron-electron dipolar couplings between 0.2 to 1.2 129 
MHz. Increasing the concentration of radical further is unsuitable for high-resolution NMR work 130 
because of line broadening and signal quenching effects at these higher radical concentrations.   131 
To improve the CE efficiency, biradicals were introduced for DNP in order to improve 132 
the electron-electron dipolar coupling critical to CE DNP while lowering the overall radical 133 
concentration to minimize paramagnetic effects (i.e., signal quenching and broadening).  By 134 
tethering two TEMPO monoradicals, one such biradical, TOTAPOL,69 has an effective electron – 135 
electron coupling of ~ 26 MHz, is water-soluble, and provides greater 1H enhancements than 136 
TEMPO based monoradicals by nearly four-fold at 5 T as shown in Figure 1. The discovery of 137 
TOTAPOL as a polarization agent and the then-unprecedented signal enhancements it produced 138 
belies the extreme sensitivity that molecular perturbations affect upon CE efficiency.  Tethering 139 
nitroxide radicals introduces several parameters that can be optimized, and synthetic organic 140 
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chemistry is the primary tool of modulating dipolar coupling (i.e. inter-electron distance), g-141 
tensor orientation, water solubility, and relaxation behaviors. All of these factors impact the 142 
resulting DNP signal enhancement.  The large synthetic opportunity has led us and others to 143 
pursue new generations of biradicals in order to achieve even greater DNP enhancements.70-73  144 
 145 
 146 
Figure 1: 13C{1H} cross-polarization of 13C-urea in a 60/30/10 v/v d8-glycerol/D2O/H2O with 20 mM 147 
TOTAPOL (top, 1H DNP) and 40 mM TEMPO (bottom, 1H DNP) acquired at 140 GHz / 212 MHz DNP 148 
NMR spectrometer with 8 W of microwave power, 4.5 kHz MAS, and 16 scans (on-signal) and 256 scans 149 
(off-signal).  150 
Here we examine a series of biradicals that are structural variants of bT-thiourea to 151 
illustrate the impact of molecular structure upon DNP enhancement. The bT-thioureas were 152 
synthesized to improve aqueous solubility exhibited by bT-urea64, but they have a lower 153 
enhancement as shown in Figure 2. The reason for this reduction in obtainable signal 154 
enhancement from bT-urea to bT-thiourea (bT-thio-3) may be due to a compression of the 155 
TEMPO moieties from the increased steric bulk stemming from the sulfur (as opposed to oxygen) 156 
in the thiourea, or alternatively it may be due to an undesirable gain in torsional mobility upon 157 
switching the urea group to a thiourea group.  We observed a further loss of DNP enhancement 158 
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upon utilizing the bT-thionourethane (bT-thio-2) biradical.  The increased conformational 159 
flexibility of the bT-thionourethane may be deleterious in that the only other conformation 160 
available to this molecule (versus BT-thiourea) features the oxygen-bound TEMPO moiety 161 
beneath the thionourethane linker.  This would result in a reduced inter-electron distance similar 162 
to other highly-coupled biradicals.64 Nevertheless, it should be noted that increasing 163 
conformational flexibility is not always deleterious.  bT-thionocarbonate (bT-thio-1) is the most 164 
conformationally flexible structural variant studied, and it shows a larger enhancement than bT-165 
thionourethane.  The slightly preferred s-trans orientation of thionocarbonates is apparently more 166 
than enough to compensate for the modestly diminished inter-electron distance resulting from the 167 
shorter C-O (vs. C-N) bonds, therefore producing a DNP enhancement similar to that of bT-168 
thiourea (BT-thio-3).   169 
V15_131025 
10 
The study of the bT-thiourea-based radicals highlights the multi-dimensional problem of 170 
developing radicals for DNP. As the study continues, more effective radicals will be discovered 171 
for DNP application to different chemistry problems. For example, many biradicals currently are 172 
optimized for dissolution in cryoprotectants such as glycerol/water or DMSO/water for studying 173 
biological samples at cryogenic temperatures.69,70 The glassing behavior of cryoprotectants 174 
disperses the radical homogeneously throughout the sample and allows uniform polarization. 175 
Amongst organic solids, some systems have meta-stable amorphous phases such as the anti-176 
inflammatory drug indomethacin,74,75 but they may not be miscible with existing biradicals such 177 
as TOTAPOL for effective DNP experiments. For this reason, we used the organic biradical bis-178 
TEMPO terephthalate (bTtereph) for our DNP study on amorphous ortho-terphenyl and 179 
amorphous indomethacin.76 We found that the biradical exhibits similar EPR and DNP profiles as 180 
TOTAPOL (Figure 3) and can be incorporated uniformly within amorphous ortho-terphenyl and 181 
indomethacin samples without needing other glassing agents.  182 
 183 
 184 
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 185 
Figure 2: 13C1H cross-polarization spectra of 13C-urea in DMSO/D2O/H2O (60:30:10, v/v) and 10 mM 186 
biradical polarizing agent (20 mM electrons) acquired at 140 GHz / 212 MHz DNP NMR spectrometer with 187 
8 W of microwave power. 1H DNP enhancements were scaled with respect to TOTAPOL using three 188 
thiourea variants. From top to bottom five radicals were studied including TOTAPOL (black), BT-urea (red), 189 
BT-thio-1 (thionocarbonate, grey), BT-thio-2 (BT-thionourethane, blue) and BT-thio-3 (BT-thiourea, green). 190 
The spectra inset are the on/off 13C[1H] CPMAS spectra scaled to the TOTAPOL enhancement in 191 
DMSO/water mixture.  192 
 193 
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 194 
Figure 3: BT-Tereph synthetic process (a) and resulting 140 GHz EPR spectrum (b) and 1H DNP field (c) 195 
profile of 10 mM bTtereph incorporated in 95% deuterated amorphous ortho-terphenyl. 196 
More recently, a new truxene-based radical, TMT, was found to be persistent, having a 197 
half-life (t1/2) of 5.8 h in a non-aqueous solution exposed to air.77 EPR at 140 GHz shows a g-198 
value very close to that of BDPA78 and a linewidth of 40 MHz (Figure 4). The radical may be 199 
ideal for supporting the CE, either alone for low-γ nuclei such as 15N, or as part of a biradical or 200 
radical mixture with Trityl OX063 or TEMPO.57,79 Current work is aimed at increasing the 201 
radical’s solubility in aqueous solvent mixtures suitable for DNP of biological samples and 202 
improving its stability under ambient conditions. 203 
 204 
 205 
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 206 
Figure 4: Chemical structures and 140 GHz EPR spectra of three narrow-line radicals: (a) Trityl, (b) TMT, 207 
and (c) SA-BDPA.  208 
ii. Direct Polarization of Low-Gamma Nuclei using Trityl 209 
Currently, the conventional wisdom is that the most efficient electron-nuclear transfer 210 
mechanism in the solid state is the CE. Consequently, many polarization agents are designed 211 
from nitroxide based radicals due to their broad EPR profile easily satisfying the CE match 212 
condition in Eq. (2) for 1H. For many systems, polarizing 1H by CE is an effective method 213 
because 1H typically have shorter relaxation times, which enables rapid signal averaging as well 214 
as offers additional gains by means of cross-polarization to other low-gamma nuclei that are often 215 
less abundant. However, direct polarization of low-gamma nuclei is also of interest considering 216 
the theoretical maximum DNP enhancement is given by the ratio γe/γI. Focusing on the five most 217 
common nuclei found in biological molecules, three of which are I=1/2 (i.e., 1H, 13C and 15N) 218 
while 2H is I=1 and 17O is I=5/2. With the exception of 1H, these nuclei are low-gamma and low 219 
natural abundance (Table 1). Moreover, the latter two nuclei are quadrupolar and consequently 220 
experience additional line broadening brought about by the interaction between the intrinsic 221 
electric quadrupole moment and the electric field gradient (EFG) generated by the surrounding 222 
environment, thereby giving rise to quadrupolar coupling. This additional interaction negatively 223 
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impacts NMR sensitivity because the quadrupolar coupling constant covers a spectral range from 224 
tens of kHz up to a few MHz. With these factors in mind, DNP experiments that directly polarize 225 
low-gamma and/or quadrupolar nuclei can potentially be useful and open new possibilities for 226 
high field DNP. 227 
For the direct polarization experiments, we can utilize narrow-line radicals that satisfy the 228 
CE match condition of low-gamma nuclei to provide effective electron polarization transfer. The 229 
water-soluble narrow-line monoradical trityl80,81 with its EPR spectrum is depicted in Figure 4. 230 
The EPR spectrum is considerably narrower than that of the common nitroxide based radicals, 231 
with a linewidth of approximately 50 MHz at 5 T.48,79,82 This narrow profile creates the 232 
possibility for both SE and/or CE mechanism to contribute to the DNP enhancement depending 233 
on the targeted nucleus. In order to determine the effectiveness of trityl on three low-gamma 234 
nuclei (i.e., 13C, 2H, and 17O), a series of DNP experiments were attempted, followed by the 235 
characterization of the mechanisms with assistance from the DNP field profiles (Figure 5).  236 
237 
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 237 
Table 1: Physical properties for select biologically relevant NMR nuclei. 238 
NMR Active 
Isotope 
N.A. (%) Magnetogyric 
Ratio 
(MHz / T) 
Sensitivity 
relative to 1H 
Theoretical εmax 
1H 99.99 42.57 1 658 
13C 1.07 10.71 1.7 x 10-4 2616 
2H 0.01 6.53 1.11 x 10-6 4291 
17O 0.037 5.77 1.11 x 10-5 4857 
 239 
   240 
For direct polarization of 13C, we obtained an enhancement of 480 (Figure 6a) using trityl, 241 
which is nearly 180% larger than using TOTAPOL.79,83 Examining more closely at the positive 242 
and negative maxima of the DNP profile, we can see there is a clear asymmetry (i.e., -380 vs. 243 
480) present. However, unlike the 1H field profile of trityl59 there is no feature in the center of the 244 
profile between the two maxima. This suggests that CE polarization mechanism is making some 245 
contribution to the DNP mechanism. Nevertheless, the nuclear Larmor frequency of 13C is 246 
slightly larger than the breadth of the trityl EPR spectrum at 5 T, and therefore by definition the 247 
SE must be considered. Looking at the positive and negative maxima of the 13C DNP field profile, 248 
the positions are in remarkably good agreement (Figure 5, blue dotted lines) with those predicted 249 
for the SE mechanism, suggesting a significant contribution.  250 
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 251 
Figure 5: Direct polarization of 13C (circle, blue), 2H (diamond, red) and 17O (triangle, grey) field profiles 252 
acquired at 5 T using 40 mM Trityl radical. 140 GHz EPR spectrum of trityl (black, top) with the 253 
appropriate SE matching conditions illustrated with the corresponding colored dashed lines. 254 
The nuclear Larmor frequencies of 2H and 17O are separated by only ~ 4 MHz at 5 T and 255 
appear to behave similarly as the field profiles are nearly overlapping. Although the electron 256 
inhomogeneous linewidth of the trityl radical is small, it is still large enough to satisfy the CE 257 
match condition for both nuclei. Both field profiles do not exhibit resolved features at frequencies 258 
corresponding to ω0S ± ω0I (Figure 5, red and grey lines), which assures that the CE mechanism is 259 
dominant for both 2H and 17O. For static DNP experiments acquired at 85 K, the 2H and 17O 260 
enhancements are 545 and 115, respectively (Figure 6b and 6c). This makes trityl still one of the 261 
most effective radicals to polarize such nuclei.47,48,84 The EPR spectrum is nearly symmetric 262 
which gives rise to the nearly symmetric positive and negative maxima in the DNP field profile. 263 
The smaller enhancement for 17O may be attributed to the comparably short polarization build-up 264 
time constant (TB = 5.0 ± 0.6 s) inhibiting saturation. This suggests a relatively fast nuclear 265 
relaxation rate that inhibits the build-up of non-Boltzmann polarization. In the case of 2H and 13C, 266 
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both nuclei exhibit larger DNP gains and both have longer TB (Table 2). The large quadrupolar 267 
coupling of 17O may also be a factor, and studies are currently underway to elucidate this. We 268 
would also like to note for all of these nuclei studied the trityl EPR line was not saturated by 269 
using 8 W of microwave power, and further enhancement gains should be possible by increasing 270 
the available microwave power. 271 
Table 2: Direct polarization of various biologically relevant nuclei using trityl at 5 T. 272 
Nucleus ε (positive) 
(± 10 %) 
ε (negative) 
(± 10 %) 
TB (s) 
ω0I/2π	  (MHz) Mechanism 
1H59 90 -81 22 212.03 SE 
13C79 480 -380 225 53.3 CE/SE 
2H 545 -565 75 32.5 CE 
17O47 115 -116 5.5 28.7 CE 
 273 
 274 
 275 
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 276 
Figure 6: Direct polarization of low-gamma nuclei using 40 mM trityl on (a) 13C (𝑣L = 53 MHz), (b) 2H (𝑣L = 277 
32 MHz) and (c) 17O (28 MHz) in a glycerol/water cryoprotectant. DNP enhanced signals were acquired 278 
using 8 W of CW microwave power with the magnetic field set to the optimum field position (positive) 279 
shown in Figure 5.  280 
iii. Sample Preparation Techniques 281 
The effective DNP polarization of a biological solid requires a few key criteria to be met. 282 
The first is to disperse the polarizing agent, which allows uniform polarization across the whole 283 
sample followed by effective spin-diffusion. For biological samples such as membrane proteins, 284 
amyloid fibrils, and peptides, a cryoprotecting matrix such as glycerol/water or DMSO/water, 285 
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which forms an amorphous “glassy” state at low temperatures to protect the sample against 286 
freezing damage, can be used to homogeneously disperse the polarizing agent for DNP. Labeling 287 
of the cryoprotecting matrix, in particular D2O, deuterated glycerol, and deuterated DMSO, can 288 
be used to fine tune 1H-1H spin-diffusion to optimize the obtainable DNP enhancement, while 289 
reverse labeling the matrix (e.g., 12C-glycerol) can minimize solvent background. In our 290 
experience, a cryoprotecting matrix that is heavily deuterated is optimal for DNP, and typically 291 
we prepare our samples in a 60/30/10 v/v d8-glycerol/D2O/H2O. However, the NMR of a 292 
homogeneous, amorphous chemical system can be limited in resolution due to line-broadening 293 
stemming from a distribution of chemical shift, a commonly observed occurrence for many 294 
organic and inorganic amorphous materials, as well as from slower side-chain dynamics at 295 
cryogenic temperatures.  Despite this limitation, DNP has been successfully applied to 296 
heterogeneous systems like the membrane protein bacteriorhodopsin14,37,38,50,85 and M286, and by 297 
combining with methods including specific labeling87-89 and crystal suspension in liquid39,42,90-92. 298 
DNP NMR also has been demonstrated on various chemical systems without adding a 299 
cryoprotectant, due to either thermal stability or self-cryoprotecting ability.76,93-96  300 
Figure 7 illustrates the various sample preparation methods both with and without 301 
cryoprotecting matrix. Figure 7a and b show DNP of amorphous and crystalline 95% deuterated 302 
ortho-terphenyl. While both samples show large 1H DNP enhancements, the crystalline sample 303 
has somewhat improved resolution of the various 13C resonances. The resolution as described 304 
above is not impacted by temperature, but the distribution in chemical shift brought about by the 305 
formation of a disordered homogeneous solid. Figure 7c and d show DNP enhanced spectra of 306 
apoferritin complex (480 kDa) prepared using either a traditional glycerol/water cryoprotectant 307 
(Figure 7c) or the new sedimentation method (SedDNP) (Figure 7d) where free water 308 
concentration is significantly reduced either by ultracentrifugation (ex situ) or via fast magic 309 
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angle spinning (in situ).93,94 Either sedimentation method results in a “microcrystalline” glass that 310 
effectively distributes the polarizing agent within the sample, allows efficient spin diffusion 311 
through the whole sample, and protects against potential damage from ice crystal formation. Both 312 
approaches provide high sensitivity, however the sedimentation method minimizes the solvent 313 
present and so reduces the solvent resonances (e.g., glycerol at ~60-70 ppm) while improving the 314 
overall filling factor. The sedimentation technique has an added advantage where cooling to 315 
cryogenic temperatures and employing DNP can offer additional structural information and 316 
constraint not observed at experiments performed at ambient condition. The low temperature 317 
spectra can provide extensive information on side chain motion and details concerning aromatic 318 
regions that are often lost due to decoupling interference at room temperature.87,97  319 
Finally, nanocrystalline preparation of GNNQQNY90,98 (Figure 7e) by suspension in a 320 
cryoprotecting matrix provides high resolution and DNP enhancement for structural 321 
understanding in both crystalline and amyloid forms. Wetting of microcrystals have also been 322 
attractive for the study of various surface science questions whereby a nitroxide biradical is 323 
dispersed into an organic solvent and added to the crystalline material of choice prior to 324 
cooling.42,92,99 Furthermore, a solvent-free dehydration approach whereby the radical is placed 325 
onto the system such as glucose or cellulose, followed by evaporation has also recently shown 326 
promise for natural abundant systems.95,96 Although these methods lead to a more heterogeneous 327 
distribution of radicals and hence polarization is not uniform within the samples, they maintain 328 
excellent sensitivity and produce excellent spectral resolution from an overall smaller effect from 329 
paramagnetic broadening. 330 
 331 
 332 
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 333 
Figure 7: MAS DNP sample preparation protocols for biophysical systems. Without cryoprotecting 334 
solvents (sans) include distributing a polarizing agent within the organic solid: amorphous (a) or crystalline 335 
(b), or using the SedDNP approach (c). Alternative is distributing the radical in a cryoprotecting solvent 336 
(avec) homogenously (d) or heterogeneously using microcrystals (e). 337 
iv. Improving DNP Instrumentation at High Fields (≥16 T) 338 
In recent years, high-field DNP has evolved beyond 9.4 T (400 MHz, 1H). The innovation 339 
in gyrotron technology has led to more adoptions of high-field DNP spectrometers such as the 340 
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600 MHz / 395 GHz53,100 (Osaka University, Japan and University of Warwick, UK), the 700 341 
MHz / 460 GHz52 (MIT, Cambridge, MA), and the commercial 600 MHz/ 395 GHz and 800 342 
MHz / 527 GHz from Bruker Biospin. However, DNP theory predicts the experiment to be less 343 
effective at high fields, with an inverse scaling of CE DNP enhancement with respect to 344 
increasing magnetic field.62 This is because the EPR linewidth of the polarizing agent increases 345 
proportionally with respect to the magnetic field (Δ ∝ Bo), meaning that the CE matching 346 
condition becomes harder to satisfy. The challenge is compounded by the difficult tasks of 347 
maintaining effective cooling capabilities at elevated MAS frequencies (e.g., limiting frictional 348 
heating) and also coupling gyrotron microwaves to the NMR sample. Therefore, considerable 349 
effort has been made to improve instrumentation in order to gain reasonable DNP enhancement at 350 
these fields. Given the inherent better resolution of high field NMR (vide infra), successful DNP 351 
can become a valuable approach to obtain structural information of challenging biological 352 
samples. 353 
One particular difficulty in implementing DNP at higher magnetic fields is the 354 
transmission of high-power microwaves from the gyrotron to the sample with minimal loss. This 355 
can be achieved by using corrugated overmoded waveguides, which are more efficient then the 356 
previously used fundamental mode waveguides, to minimize mode conversion and ohmic loss. At 357 
the MIT-FBML, the microwave source of the 700 MHz DNP system is a 460 GHz gyrotron 358 
operating in the second harmonic, in a TE11,2 mode.101 The produced microwaves are guided 359 
through a ~ 465 cm long, 19.05 mm inner diameter (i.d.) corrugated waveguide that connects the 360 
16.4 T NMR magnet and the 8.2 T gyrotron magnet. The alignment is critical to maintain a clean 361 
microwave mode with minimum energy loss through the long waveguide, and we were able to 362 
achieve less than 1 dB loss from the gyrotron window to the final miter-bend that directs the 363 
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microwaves into the probe body. The final ~85 cm of the waveguide is located within the NMR 364 
probe, and it was initially constructed by a series of down tapers reducing the i.d. from 19.05 to 365 
4.6 mm. using a combination of smooth-walled macor, aluminum and copper waveguide portions. 366 
However, due to the significant loss of microwave power associated with 4.6 mm waveguide and 367 
macor sections at 460 GHz (λ = 0.65 mm), several changes were implemented to improve 368 
microwave transmission to the sample. A newly designed waveguide for our home-built DNP 369 
NMR probes now includes a modified tapered and corrugated aluminum waveguide section from 370 
19.05 to 11.43 mm i.d. at the base of the NMR probe (Figure 8), and at which point the 371 
microwaves are directed toward the stator via a 45o miter-bend. The microwaves are then 372 
reflected off a copper mirror into a multi-section corrugated waveguide with an 11.43 mm i.d. 373 
consists of a stainless steel section at the base which acts as a thermal break followed by two 374 
copper sections. The final 50 mm portion approaches the reverse magic-angle microwave beam 375 
launcher features an aluminum corrugated part that is tapered from 11.43 to 8 mm i.d. in order to 376 
direct and focus the microwave beam into the 3.2 mm MAS stator housing. A small Vespel® 377 
washer is installed prior to the final taper to act as an electrical break between the microwaves 378 
and the RF. Finally, the waveguide is terminated by a copper microwave launcher at the reverse 379 
magic-angle, and aligned using three brass set screws. With these modifications, the new probe 380 
waveguide design reduces the loss of microwave power being transmitted to the sample while 381 
maintaining the effective Gaussian beam content. The new design has improved the high-field 382 
DNP enhancements by 40-50%, from -38 (4) to -53 (5) on a sample of 1 M 13C-urea at 80 (2) K 383 
and from -21 to -33 on a sample of 0.5 M U-13C-proline. Figure 9 shows a DNP enhanced 13C-384 
13C DARR spectrum of U-13C-proline that illustrates the good resolution and sensitivity gain that 385 
can be achieved with high field DNP. 386 
 387 
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 388 
Figure 8: Artistic rendering of the new waveguide designed for the 460 GHz / 700 MHz DNP NMR 389 
spectrometer (FBML-MIT). The inset is an 13C1H CP on/off spectrum of 1M 13C-Urea in d8-390 
glycerol/D2O/H2O (v/v 60/30/10) with 10 mM TOTAPOL and packed into a 3.2 mm sapphire rotor, 391 
acquired at 80 K and a spinning frequency of 5.2 kHz.  392 
 393 
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 394 
Figure 9: (A) 13C-13C DARR spectrum of U-13C-Proline (0.5 M) in d8-glycerol/D2O/H2O (v/v 60/30/10) with 395 
10 mM TOTAPOL (1H enhancement of 33 (3)) using a 20 ms DARR mixing period. (B) An enlarged 396 
aliphatic and carbonyl region illustrating the connectivity of U-13C-Proline. Sample was packed into a 3.2 397 
mm sapphire rotor, data was acquired with 8 scans, rd = 20 s, 64 increments, 11 W of microwave power, 398 
sample temperature 82 (2) K and a spinning frequency of 9,200 Hz. 399 
 400 
We recently used the improved 700 MHz DNP system to study apoferritin, which is an 401 
important protein for maintaining available non-toxic soluble forms of iron in various 402 
organisms.102  Apoferritin, the iron-free form, is a 480 kDa globular protein complex consisting 403 
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of 24 subunits, with each unit being 20 kDa in size. The protein is a challenging system for NMR 404 
due to its large size comprised of nearly 4,000 residues.103 Nevertheless, chemical shift separation 405 
can be achieved at higher magnetic fields, and structural insight can be gained through a 406 
combination of approaches including solution and solid-state methods (i.e., SedNMR)104,105 as 407 
well as combining with DNP (i.e., SedDNP).93 Figure 10 is an overlay of U-13C-apoferritine 408 
collected at 212 MHz / 140 GHz and 697 MHz / 460 GHz employing a 13C-13C PDSD dipolar 409 
recoupling experiment. Although the DNP enhancement is lower at the higher field (ε = -6, with 410 
ε† = -21 accounting for Boltzmann population difference between cryogenic and room 411 
temperature) compares to the lower field enhancement (ε = 42), we can see that the aliphatic 412 
region is significantly more dispersed in the higher field spectrum enabling differentiation 413 
between the Cα and Cβ region. Continuing effort at improving instrumentation and developing 414 
new radicals will potentially increase enhancement further than what is currently obtainable. 415 
416 
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 416 
 417 
 418 
 419 
Figure 10: 13C-13C correlation spectrum of U-13C-apoferritin at 5 T (red) and 16.4 T (blue) using DNP MAS 420 
NMR.  421 
Conclusion 422 
 In this topical review, we discussed the recent DNP efforts at MIT-FBML including new 423 
radical polarization-agent development, direct polarization of low-gamma nuclei, various sample 424 
preparation methods, and hardware improvements to our 700 MHz / 460 GHz DNP NMR 425 
spectrometer. As developmental efforts continue and along with the recent commercialization of 426 
DNP systems, we foresee the method achieving greater sensitivity for NMR and becoming a 427 
more general method to study various biological and chemical systems. We expect the wider 428 
adoption of DNP to be a very fruitful endeavor leading to many new and exciting scientific 429 
discoveries. 430 
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